What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Gene
Yoshinao Oda mainly focuses on Pathology, Cancer research, Immunohistochemistry, Sarcoma and Internal medicine.
He combines subjects such as Cancer and Metastasis with his study of Pathology.
His work carried out in the field of Cancer research brings together such families of science as Protein kinase B, Carcinogenesis, SMARCB1, Tumor progression and Cyclin D1.
His work in Immunohistochemistry addresses issues such as Fluorescence in situ hybridization, which are connected to fields such as Mesothelioma and Receiver operating characteristic.
His research integrates issues of Missense mutation, Catenin and Dermatofibrosarcoma protuberans in his study of Sarcoma.
His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology, Endocrinology and Oncology.
His most cited work include:
- Expression profile of class I histone deacetylases in human cancer tissues (260 citations)
- c-kit and PDGFRA mutations in extragastrointestinal stromal tumor (gastrointestinal stromal tumor of the soft tissue). (196 citations)
- Apparent Diffusion Coefficients of Breast Tumors : Clinical Application (195 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Pathology, Cancer research, Immunohistochemistry, Internal medicine and Cancer.
His work deals with themes such as Metastasis and Adenocarcinoma, which intersect with Pathology.
Yoshinao Oda has researched Cancer research in several fields, including Cell culture, Cell growth, Carcinogenesis, Cancer cell and Tumor progression.
His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Endocrinology and Oncology.
The Oncology study combines topics in areas such as Breast cancer and Chemotherapy.
He most often published in these fields:
- Pathology (46.40%)
- Cancer research (26.23%)
- Immunohistochemistry (24.59%)
What were the highlights of his more recent work (between 2018-2021)?
- Cancer research (26.23%)
- Internal medicine (22.84%)
- Immunohistochemistry (24.59%)
In recent papers he was focusing on the following fields of study:
Yoshinao Oda focuses on Cancer research, Internal medicine, Immunohistochemistry, Pathology and Gastroenterology.
His work in the fields of Tumor microenvironment overlaps with other areas such as Chemistry.
Tumor microenvironment is frequently linked to Tumor progression in his study.
In his study, Breast cancer is strongly linked to Oncology, which falls under the umbrella field of Internal medicine.
The concepts of his Immunohistochemistry study are interwoven with issues in Hepatocellular carcinoma, Carcinoma, Immunotherapy and Fluorescence in situ hybridization.
His Sarcoma and Biopsy study are his primary interests in Pathology.
Between 2018 and 2021, his most popular works were:
- Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation (17 citations)
- Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens (17 citations)
- 18F-FDG uptake in PET/CT is a potential predictive biomarker of response to anti-PD-1 antibody therapy in non-small cell lung cancer. (16 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Gene
Cancer research, Internal medicine, Immunohistochemistry, Pathology and Tumor microenvironment are his primary areas of study.
When carried out as part of a general Cancer research research project, his work on Cancer-Associated Fibroblasts is frequently linked to work in Chemistry, therefore connecting diverse disciplines of study.
His Internal medicine research incorporates elements of Gastroenterology and Oncology.
The study incorporates disciplines such as Survival rate, Adenocarcinoma, Melanoma, Lung and Immunotherapy in addition to Immunohistochemistry.
His Pathology research is multidisciplinary, incorporating elements of Solitary fibrous tumor and Metastasis.
Yoshinao Oda interconnects Hepatocellular carcinoma and Epidermal growth factor receptor in the investigation of issues within Tumor microenvironment.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
